Goldman Sachs’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Buy |
109,404
+23,994
| +28% | +$103K | ﹤0.01% | 4292 |
|
|
2025
Q1 | $319K | Sell |
85,410
-3,641
| -4% | -$13.6K | ﹤0.01% | 4471 |
|
|
2024
Q4 | $903K | Sell |
89,051
-63
| -0.1% | -$639 | ﹤0.01% | 3974 |
|
|
2024
Q3 | $1.11M | Sell |
89,114
-63,582
| -42% | -$792K | ﹤0.01% | 3696 |
|
|
2024
Q2 | $1.99M | Buy |
152,696
+52,145
| +52% | +$679K | ﹤0.01% | 3194 |
|
|
2024
Q1 | $2.28M | Buy |
100,551
+14,111
| +16% | +$320K | ﹤0.01% | 3133 |
|
|
2023
Q4 | $1.12M | Sell |
86,440
-41,230
| -32% | -$535K | ﹤0.01% | 3559 |
|
|
2023
Q3 | $2.57M | Buy |
127,670
+19,602
| +18% | +$394K | ﹤0.01% | 2939 |
|
|
2023
Q2 | $2.9M | Buy |
108,068
+10,125
| +10% | +$272K | ﹤0.01% | 2961 |
|
|
2023
Q1 | $5.71M | Buy |
97,943
+27,501
| +39% | +$1.6M | ﹤0.01% | 2430 |
|
|
2022
Q4 | $3.59M | Sell |
70,442
-19,903
| -22% | -$1.02M | ﹤0.01% | 2882 |
|
|
2022
Q3 | $7.4M | Sell |
90,345
-6,082
| -6% | -$498K | ﹤0.01% | 2356 |
|
|
2022
Q2 | $6.52M | Buy |
96,427
+36,500
| +61% | +$2.47M | ﹤0.01% | 2451 |
|
|
2022
Q1 | $6.63M | Sell |
59,927
-8,665
| -13% | -$958K | ﹤0.01% | 2579 |
|
|
2021
Q4 | $6.62M | Buy |
68,592
+2,900
| +4% | +$280K | ﹤0.01% | 2583 |
|
|
2021
Q3 | $5.74M | Sell |
65,692
-1,356
| -2% | -$118K | ﹤0.01% | 2693 |
|
|
2021
Q2 | $10.4M | Sell |
67,048
-13,750
| -17% | -$2.13M | ﹤0.01% | 2221 |
|
|
2021
Q1 | $12.8M | Buy |
80,798
+10,481
| +15% | +$1.65M | ﹤0.01% | 2021 |
|
|
2020
Q4 | $16.3M | Buy |
70,317
+12,672
| +22% | +$2.94M | ﹤0.01% | 1704 |
|
|
2020
Q3 | $12.6M | Sell |
57,645
-75,694
| -57% | -$16.6M | ﹤0.01% | 1781 |
|
|
2020
Q2 | $37.9M | Buy |
133,339
+69,389
| +109% | +$19.7M | 0.01% | 1052 |
|
|
2020
Q1 | $18.4M | Buy |
63,950
+26,880
| +73% | +$7.75M | 0.01% | 1377 |
|
|
2019
Q4 | $10.7M | Sell |
37,070
-1,338
| -3% | -$385K | ﹤0.01% | 2006 |
|
|
2019
Q3 | $5.54M | Buy |
38,408
+27,357
| +248% | +$3.95M | ﹤0.01% | 2257 |
|
|
2019
Q2 | $993K | Buy |
11,051
+147
| +1% | +$13.2K | ﹤0.01% | 3197 |
|
|
2019
Q1 | $955K | Buy |
10,904
+176
| +2% | +$15.4K | ﹤0.01% | 3279 |
|
|
2018
Q4 | $1.51M | Sell |
10,728
-7,864
| -42% | -$1.11M | ﹤0.01% | 2928 |
|
|
2018
Q3 | $4.75M | Sell |
18,592
-15,274
| -45% | -$3.9M | ﹤0.01% | 2460 |
|
|
2018
Q2 | $8.63M | Buy |
33,866
+26,430
| +355% | +$6.74M | ﹤0.01% | 2083 |
|
|
2018
Q1 | $1.5M | Buy |
7,436
+2,229
| +43% | +$449K | ﹤0.01% | 3003 |
|
|
2017
Q4 | $750K | Sell |
5,207
-176
| -3% | -$25.4K | ﹤0.01% | 3267 |
|
|
2017
Q3 | $887K | Buy |
5,383
+2,247
| +72% | +$370K | ﹤0.01% | 3277 |
|
|
2017
Q2 | $426K | Sell |
3,136
-2,179
| -41% | -$296K | ﹤0.01% | 3614 |
|
|
2017
Q1 | $1.02M | Sell |
5,315
-1,465
| -22% | -$282K | ﹤0.01% | 3092 |
|
|
2016
Q4 | $956K | Buy |
6,780
+3,546
| +110% | +$500K | ﹤0.01% | 3123 |
|
|
2016
Q3 | $472K | Buy |
3,234
+483
| +18% | +$70.5K | ﹤0.01% | 3470 |
|
|
2016
Q2 | $277K | Buy |
2,751
+2,035
| +284% | +$205K | ﹤0.01% | 3669 |
|
|
2016
Q1 | $96K | Buy |
+716
| New | +$96K | ﹤0.01% | 4040 |
|
|
2015
Q4 | – | Sell |
-301
| Closed | -$47K | – | 4544 |
|
|
2015
Q3 | $47K | Sell |
301
-4,091
| -93% | -$639K | ﹤0.01% | 4349 |
|
|
2015
Q2 | $1.79M | Buy |
4,392
+889
| +25% | +$363K | ﹤0.01% | 2627 |
|
|
2015
Q1 | $1.61M | Buy |
3,503
+589
| +20% | +$270K | ﹤0.01% | 2664 |
|
|
2014
Q4 | $1.64M | Buy |
2,914
+2,277
| +357% | +$1.28M | ﹤0.01% | 2629 |
|
|
2014
Q3 | $334K | Sell |
637
-62
| -9% | -$32.5K | ﹤0.01% | 3587 |
|
|
2014
Q2 | $488K | Sell |
699
-731
| -51% | -$510K | ﹤0.01% | 3368 |
|
|
2014
Q1 | $663K | Buy |
+1,430
| New | +$663K | ﹤0.01% | 3214 |
|